Jump to content
View in the app

A better way to browse. Learn more.

99NICU

A full-screen app on your home screen with push notifications, badges and more.

To install this app on iOS and iPadOS
  1. Tap the Share icon in Safari
  2. Scroll the menu and tap Add to Home Screen.
  3. Tap Add in the top-right corner.
To install this app on Android
  1. Tap the 3-dot menu (⋮) in the top-right corner of the browser.
  2. Tap Add to Home screen or Install app.
  3. Confirm by tapping Install.

Stefan Johansson

Administrators
  • Joined

  • Last visited

  • Country

    Sweden
  1. @piatkat i read through the revision more closely and it does not fit 100% with the Quiz software, e.g. in a Study Mode Quiz, only one answer can be marked correct, and if we go for a regular "hit a score" quiz with multiple correct replies also possible, the partially correct replies are tricky... And there is now final info screen where we can post the last part, the Case Closure. I will have a think later, maybe possible to combine the Quiz with a forum thread, lets see.
  2. Thanks to our latest page about Latest Research with the automated feed on PubMed, this AAP Clinical Report came on my radar about Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy. Great write-up about the background and evidence about HIE and hypothermia treatment. In the recommendation (last page!), AAP recommends 1) blood gas aligning with asphyxia and 2) moderate-severe HIE, before initiating hypotherma. Here in the Outer Rim (i.e. Sweden!), we have a more diverse #1 criteria in our national guideline, Apgar score ≤5 at 10 min, need of ongoing resusc beyond 10 min, and/or acidosis (pH <7.0 or BE <-16 first 60 min). We published about those so-called initial criteria, and one main take home was that the acidosis criteria as such had little impact on the risk to need hypothermia treatment. Low Apgar score and prolonged need of resusc was much more predictive. Apologies for the long intro 🙂 to what I am thinking about - how do you select infant for hypothermia, i.e. what criteria do you apply before cooling down an infant with HIE? Do you have a local, regional or national guideline for this?
  3. Much better, I will edit all once I have some new time for copy/paste.
  4. Thanks @Vicky Payne - there are many things one can do in a gondola :) And of course you are right, AI is what it is... But maybe a quick and dirty thing is good enough at this time point? What we can do is something along our old idea, that we try to get some forums disc going, and promote the quiz, and... interview the authors. @all - what is the final verdict, ditch or distribute this Quiz to the world?
  5. IS IT FINALLY TIME TO DITCH THE DUCT? Find out at Global Neonatal Journal Club Wednesday 4th February at | 17:00 Melbourne | 14:00 Perth | 19:00 Auckland | 14:00 Singapore | 06:00 London | 11:30 New Delhi | 08:00 Cape Town | 22:00 Los Angeles | 14:00 Beijing | There are no topics more controversial in neonatal intensive care than the diagnosis and management of the patent ductus arteriosus (PDA) in very preterm infants. Through the years (and around the world) practice has varied dramatically, from early screening echocardiogram and universal treatment (including surgical closure), to completely ignoring the PDA. It is only in recent years that large randomised trials with important clinical outcomes have emerged to help guide practice. We will review the latest large RCT of expectant vs. medical management of the PDA, including an interview with the first author Prof Matthew Laughon (USA) and input from an expert international panel including Dr Tim Hundsheid (The Netherlands - PI of the BeNeDuctus PDA trial) and A/Prof Koert de Waal (Australia), as well as our hosting panel Prof Brett Manley, Prof Ju Lee Oei and Dr Shiraz Baduradeen. Don't miss the first GNJC of 2026 as we discuss this hugely controversial topic! Read more and register here!
  6. Thanks for sharing this question. I translated our national guideline in Sweden, hope this helps. Indication for rotavirus vaccination: born at gestational age ≥ 25+0 weeks: can be given in the neonatal unit. first dose given from 6 weeks of chronological age, and must be given before 12 weeks of chronological age. the first dose may be given from gestational week 34 together with other vaccines if such are needed if possible, give the vaccine 2–3 days before discharge. second dose should preferably be given at least 4 weeks after the first dose and no later than 16 weeks of chronological age. contraindications: previous intestinal surgery, previous intussusception, congenital malformation of the gastrointestinal tract, a history of NEC regardless of stage and treatment (consult pediatric surgery), immunodeficiency (SCID), and/or congenital sucrase deficiency.
  7. Yes @piatkat , time flies! I guess the links to those files got corrupted in on of our software transitions. I can check if I find them on our server but likely difficult. However, this made me think that we could use our Quiz feature for educational MCQs based on review articles and/or textbook material. Lets discuss!
  8. In Stockholm, SE, these infants are sedated via the PICU, as treatment is done via them. So, I honestly don’t know about details. Spoke to a UK colleague today, at a large referral center, and they used chloralhydrate as the standard sedation + topical analgesia, with midazolam as backup (rarely needed)
  9. until

    The QR code does not go to a registration page, could you please add a link about where to register?
  10. Tricky situation. A low dose of clonidine, as an adjunkt to opiods may help. But keep an eye on blood pressure!
  11. Thanks Mariana, great topic, and an everyday question. Our standard in Sweden is https://janusmed.se/amning, will share more later 😀
  12. I suppose many of you already know and follow the Tiny Baby Collaborative, and international research group dedicated to improving the lives of children born at ≤23 weeks’ gestation and their families. They do excellent educational webinars about this niche population of preterm infants. You find them all on their site here -> https://www.tinybabycollaborative.org/webinars Check out the latest below:
  13. The AAP organises trainees and early career neonatologists in a section called NeoTECaN and I just got on my radar that they run great journal clubs. They publish very informative and educational material on their Youtube channel. I wanted to share their Journal Clubs here, very good for all professions (and experience level) in the NICU! Here's a first one in which Dr. Gayathri Sreenivasan (Neonatal-Perinatal Fellow, New York Medical College) reviews the MoCHA Trial - about extended caffeine through discharge for very preterm infants. The Journal club is moderated by Dr. Wally Carlo (Trial PI, University of Alabama at Birmingham) and Dr. Barbara Schmidt (University of Pennsylvania and McMaster University).
  14. today, on November 17, is World Prematurity Day. We, being neonatal health care professionals, are much aware of the many unmet needs for preterm newborns. But, for the larger context, there is still much to do, creating awareness of the large public health challenge to reduce the burden of preterm birth. If you have some time today, join the WHO webinar about the launch of a new global clinical practice guide for Kangaroo Mother Care (KMC). Register here!

Account

Navigation

Search

Configure browser push notifications

Chrome (Android)
  1. Tap the lock icon next to the address bar.
  2. Tap Permissions → Notifications.
  3. Adjust your preference.
Chrome (Desktop)
  1. Click the padlock icon in the address bar.
  2. Select Site settings.
  3. Find Notifications and adjust your preference.